|
Medical News -
Eye Health
|
|
The Glaucoma Research Foundation announced that Adrienne L. Graves, PhD has been appointed to its Board of Directors. Dr. Graves is President and CEO of Santen Inc., a wholly owned subsidiary of Japan's Santen Pharmaceutical Co., Ltd. (Tokyo Stock Exchange: 4536). Kuldev Singh, MD, MPH, Board Chair of the Glaucoma Research Foundation and Director of Glaucoma Service and Professor of Ophthalmology at Stanford University, commented, "Having observed the quality of Dr. Read more:
|
